Podcasts about Burwell

This Day in Legal History: Mutiny on the BountyOn April 28, 1789, one of the most famous acts of rebellion at sea occurred aboard the HMS Bounty. Captain William Bligh and 18 loyal crew members were forcibly set adrift in the Pacific Ocean by mutineers led by Fletcher Christian. The incident exposed deep tensions over leadership, working conditions, and authority in the Royal Navy. British law at the time treated mutiny as a capital offense, reflecting the critical importance of discipline aboard ships. After the mutiny, an intense search for the culprits began, with some mutineers eventually captured and returned to England to stand trial.The ensuing court-martial proceedings offered early insight into naval justice and the balancing act between maintaining strict command and recognizing crew grievances. Defendants argued that Bligh's harsh leadership provoked the uprising, but the Admiralty was unwavering in its stance against insubordination. Of those captured, three were found guilty and hanged, while others were acquitted or pardoned. The legal handling of the mutiny reinforced the severe consequences for undermining maritime authority. It also prompted discussions about humane treatment of sailors, subtly influencing later reforms in naval discipline.The Mutiny on the Bounty became a lasting symbol in both legal and cultural history, illustrating how law functions as both a tool of control and a response to the realities of human endurance and dissent at sea.Seven Democratic senators on the U.S. Senate Judiciary Committee have requested information from the Justice Department regarding recent changes within its civil rights division under President Donald Trump's administration. In a letter sent Friday, they expressed concern over the reassignment of several career officials, suggesting these moves could be an attempt to pressure staff into leaving and shift the division's enforcement priorities. Since Trump's return to office and the appointment of Pam Bondi as Attorney General, the department has paused investigations into police misconduct, launched a gun rights investigation in Los Angeles, and altered its approach to transgender rights cases. It has also opened investigations into antisemitism related to pro-Palestinian protests at colleges. The senators emphasized the importance of nonpartisan career staff in maintaining the integrity of civil rights enforcement. About a dozen senior attorneys specializing in voting, police, and disability rights were among those reassigned. The Justice Department has not yet commented on the senators' letter.Democratic senators question US Justice Department on civil rights changes | ReutersThe U.S. Drug Enforcement Administration announced that federal law enforcement agencies raided a nightclub in Colorado Springs, arresting over 100 individuals who were in the U.S. illegally. The operation resulted in 114 arrests out of more than 200 people present at the venue, making it one of the largest immigration-related raids since President Donald Trump's second term began. Attorney General Pam Bondi stated that the raid also led to the seizure of cocaine, methamphetamine, and "pink cocaine," and two individuals were arrested on outstanding warrants. Bondi mentioned links to gangs like Tren de Aragua and MS-13, although she did not directly confirm whether those arrested were affiliated with them. The DEA noted that occupants were given multiple warnings before the raid was executed. This action is part of an intensifying crackdown on illegal immigration under Trump's renewed immigration policies. Separately, ICE recently reported nearly 800 immigration-related arrests in Florida during a multi-agency operation.Over 100 migrants in the US illegally arrested in Colorado nightclub | ReutersThe Supreme Court has requested additional briefing in a case challenging the Affordable Care Act's mandate that insurers cover preventive services, like cancer screenings, at no cost. The justices specifically want the parties to address whether the Secretary of Health and Human Services has the legal authority to appoint members of the U.S. Preventive Services Task Force, which advises on covered treatments. During arguments on April 21, Justice Neil Gorsuch questioned whether the power to remove officials necessarily implies the power to appoint them, an issue the lower court had not considered. The Fifth Circuit Court of Appeals previously ruled that the task force's structure violated the Constitution's appointments clause, arguing its members must be nominated by the president and confirmed by the Senate. The Trump administration contends the task force members are merely "inferior officers" under the HHS Secretary's control. The case also involves objections by Texas businesses and residents to mandatory coverage of HIV prevention drugs, claiming unconstitutional imposition by unelected officials. Supplemental briefs are due by May 5, and while rare, this is not the first time the Court has asked for more information after oral arguments, as seen in past cases like Zubik v. Burwell and Citizens United v. FEC.Supreme Court Orders New Briefs After Obamacare Case Argued (1) This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.minimumcomp.com/subscribe

01:00 I read in the FT that Trump is halfway to instituting a police state 02:00 FT: Trump is halfway to making America a police state, https://www.ft.com/content/4c4b0f14-3e85-4436-94de-204d3f518f3c 03:00 Will Trump revoke Harvard's tax exempt status? https://ncofnas.com/p/with-amy-wax-for-and-against-tds 08:00 George Friedman on How Geopolitics Drives Trump's Tariffs, https://www.youtube.com/watch?v=o0YJSEMy0sc 16:00 Nathan Cofnas: With Amy Wax: For and against TDS, https://ncofnas.com/p/with-amy-wax-for-and-against-tds 25:00 No Trade Is Free: Changing Course, Taking on China, and Helping America's Workers, https://www.amazon.com/No-Trade-Free-Changing-Americas/dp/0063282135 45:00 What is the left and right? https://yourmoralleader.blogspot.com/2025/04/what-is-left-and-right.html 57:00 Michael joins to discuss right-wing TDS, https://x.com/Michaelmvlog 1:25:00 Josh Blackman: Remember When The Obama Administration Pressured Baker Hostetler To Drop Its Representation In House of Representatives v. Burwell?, https://reason.com/volokh/2025/03/13/remember-when-the-obama-administration-pressured-baker-hostetler-to-drop-its-representation-in-house-of-representatives-v-burwell/ 1:30:00 How Democrats use NGOs to accomplish the agenda they can't capture via politics, https://nypost.com/2025/04/14/opinion/how-democrats-used-ngos-to-end-run-voters-and-democracy/ 1:36:00 Big Law Seems To Be Winning The Narrative War Against MAGA, https://yourmoralleader.blogspot.com/2025/04/big-law-seems-to-be-winning-narrative.html 1:44:00 New Parents - SNL, https://www.youtube.com/watch?v=-ryBqgkOw4U 1:45:00 Medication Ad - SNL, https://www.youtube.com/watch?v=cQ3jwffRn10 1:48:30 President Biden's Cognitive Issues in 2024: A CHARLIE ROSE Global Conversation with Chris Whipple, https://www.youtube.com/watch?v=hQzy14CImqw 1:51:20 DTG: Back in the K-Hole, https://decoding-the-gurus.captivate.fm/episode/special-decoding-back-in-the-k-hole 2:01:30 Naomi Klein: It was Neoliberal Capitalism all along!, https://decoding-the-gurus.captivate.fm/episode/naomi-klein-it-was-neoliberal-capitalism-all-along 2:12:40 Give Trump credit for changing his mind, https://www.youtube.com/watch?v=5wi-OS9rpYc

Send us a textOn this episode of ‘Network Outdoors The Podcast' Brandon Malson speaks with Tucson, Arizona Chapter Member, Investment Analyst and Outdoorsman, Chris Burwell!Chris shares his story of how he got into deer hunting while growing up in the midwest Illinois and Missouri, how different his experience has been now hunting in the southern desert regions, challenges he's faced getting into pursuing game birds and different wild game, some great stories, and much more!Thank you so much for listening and for your support!If you or someone you know finds value in connecting with other outdoors men & women, please drop us a line and we will get you plugged in.Be sure to follow us on social @networkoutdoors and subscribe to our YouTube Channel: https://www.youtube.com/channel/UCzpCfJXk0eoo0oKiEFPmWIATo stay up-to-date on events, trips and networking opportunities sign up for our email list at our website www.NetworkOutdoors.com.Until next time - signing off!

What if the biggest creative breakthroughs come from breaking your own rules? In this Black History Month mini-episode, we explore the remarkable artistic journey of 97-year-old sculptor and painter Lillian Thomas Burwell, whose creative evolution spans nearly a century of American history. Episode Highlights: Growing up during the Great Depression, Burwell learned transformative creativity from watching her mother turn silk shipping sacks into elegant curtains Her artistic journey from realism to bold abstract expressionism during the Civil Rights era Her innovative techniques combining canvas, wood, and heated plexiglass Burwell's intuitive creative process: "I don't know what the second step is until the first step is completed" Key Quote: "I've always believed in taking chances and going into unexplored territory." - Lillian Thomas Burwell Chapters:  00:00 Introduction to Artistic Resilience 01:27 Lillian Thomas Burwell: A Journey Through Time 03:54 The Evolution of Artistic Expression 06:30 Transformation and Creative Courage   About the Artist: Lillian Thomas Burwell's work represents a lifetime of artistic innovation, from her early influences during the Depression to her current sculptural pieces that seem to grow from walls "like living things." Her art demonstrates the power of transformation and creative courage. Connect With Us: Website: Martine SeverinFollow on Instagram: Martine | This Is How We CreateSubscribe to the Newsletter: Martine's Substack Watch the Youtube Version of this video This episode of This is How We Create is produced and edited by Martine Severin. Production Credits: Martine Severin produced and edited this episode of This is How We Create. Previous Episodes in This Series: Episode 112: Roy de Carava Episode 114: Margaret Burroughs  

Scott Burwell, PhD, is the founder and CEO of Neurotype Inc. Scott shares his journey from a background in experimental psychology to establishing Neurotype, a company developing brain therapeutics to address cravings in substance use disorders. He discusses the innovative use of EEG technology to measure brain responses to stimuli, providing an objective biological assessment and treatment of cravings. Scott emphasizes the importance of integrating science-led approaches in creating medical devices and reflects on the challenges and rewards of leading a MedTech startup.   Guest links: https://www.neurotype.io | https://www.linkedin.com/in/scottjburwell/ | https://www.linkedin.com/company/neurotype Charity supported: Equal Justice Initiative Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com.  PRODUCTION CREDITS Host: Lindsey Dinneen Editing: Marketing Wise Producer: Velentium   EPISODE TRANSCRIPT Episode 049 - Scott Burwell, PhD [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello, and welcome back to another episode of The Leading Difference podcast. I'm your host, Lindsey, and I'm so excited to introduce you to my guest today, Scott Burwell. Scott is the founder and CEO of Neurotype Inc, developer of new brain therapeutics to make environmental triggers less problematic for people in recovery for substance use disorders and other addictions. Well, hello, Scott. Thank you so much for joining us today. I'm so excited to speak with you. [00:01:17] Scott Burwell: Great. Thanks so much for having me, Lindsey. Thanks. [00:01:19] Lindsey Dinneen: Of course. Well, would you mind by starting off and tell us a little bit about yourself, your background, and maybe what led you to MedTech? [00:01:28] Scott Burwell: Sure. Yeah. So, I have a background in experimental psychology, a PhD in psychology from the University of Minnesota. And kind of what led me to that was experience: my family had a liquor store growing up and I worked there for many years. And so I saw firsthand from behind the counter people with substance use disorders occasionally, and just knowing from extended family, substance use disorders, and it was an interesting observation to me to see different people, how they get to a substance use disorder. Some through genetic propensity and some through experiences in their life. And that led me to get a PhD in psychology where I really focused on the genetics and physiology underlying substance use disorders. And during this time of getting my PhD, I was always trying to think of, where does my skill set and my interest align in the future? What kind of job am I going to have after this? So I looked around. I had some experience, thought, "Could I go the academic route? Could I apply for grants, be a professor at a university?" That approach, which is a very good approach for some people, where your main outcome are publications and grants and dissemination of science. And then I also looked at industry, but a lot of the companies in industry weren't doing exactly what I wanted to do, which was take these biomarkers that we were studying in psychology and transforming that into medical device or medical innovations. And then the third path that I didn't quite see at the time was this sort of like rabbit hole, this unknown path of medical device innovations or startup innovations. And it was an eye-opener to me through some programs at the National Institute of Health, National Institute on Drug Abuse, that led us to this opportunity that actually, I could start my own startup in this space. And and I'm happy to talk a little bit more about that, that later. But really, this opportunity to make something new, based on the science that we know today, and based on the opportunity and the gap in terms of what people are being treated for with these substance use disorders. So that's kind of what led me down the path, and happy to talk about it today. [00:03:41] Lindsey Dinneen: Yeah, excellent. Well, thank you for that. And yeah, I'm so excited to delve into so many aspects of your story. So going back just a little bit, you had this childhood where you were observing and you were seeing what was happening to some folks and you thought, "Okay, maybe there's a better way, or at least I'd like to understand more about this." But now, were you always sort of science minded and kind of interested in going into psychology, or did that come about as a result? How did that interest develop? [00:04:10] Scott Burwell: Yeah, really, I never saw myself getting a PhD, never saw myself going to an academia setting. People with graduate degrees, people with doctoral degrees-- all those people seem to be other people and not something that what we did. But my parents really instilled an appreciation of higher education in myself and my two older sisters. But again, it was never this plan for me to go out and get an higher education, PhD degree. I think that what really led me to the path was just try to understand myself. I think that's what led me to psychology. It was a psychology class in behavior genetics that I took in undergraduate that, you know, behavior genetics is the field of understanding how your genes and your rearing environment lead to who you are and influence who you are. And it was one of these, this realization that actually it's not just your experiences, it's not all just the soft, mental processing and soft psychological experience. There's really a physical, biophysical basis, to a lot of who you are and who you turn out to be. And I think that was really eye-opening to me and helpful for me understanding who I was and how I am in the world. And I think, you know, just that little bit of information of understanding, there's this objective information that is programmed in your genes or programmed in your physiology that influences who you are in everyday life, that I found super interesting and eventually led me to work at the Twin Study at the University of Minnesota. And then and then while I was there, I realized there's a lot of people getting PhDs that I'm not that much different from and we're all just curious people. And it's an opportunity for me to, you know, if I apply myself, it was an opportunity for me to pursue a field. [00:06:06] Lindsey Dinneen: That's very cool. Yeah. Okay. So, so you're pursuing this field and you've already had this background and interest in helping folks who have these substance abuse disorders, and I'm wondering, what were you observing as you have now developed this company? And I'm so excited to dive into that as well, but a little bit before that, what were your observations when you started realizing, "Okay there's a gap in the way that we're treating this or handling this or responding to this." And then what was the outcome for you that you thought, "Okay, let's try something different." [00:06:42] Scott Burwell: Yeah. So a couple of things. I think the first thing is that, the treatment of substance use disorders and all behavioral addictions and to some degree mental health is been sort of a parallel development. It's been a, it's been a parallel field that's been outside of the rest of the way that medicine is traditionally done. And so, even though we have for some substance use disorders medications for management of the substance use disorder. Or there are social support groups, AA, Narcotics Anonymous also, that help provide social support to people with substance use disorders. These are sort of groups and services that have been built outside of traditional medicine. And with the exception of these services, there haven't been too many medical innovations, FDA regulated innovations that doctors can prescribe for people with substance use disorders. And this is despite decades of research that are showing there are biological underpinnings of substance use disorders. There are biological interventions that, that can potentially help people with these afflictions. And so, that was one of the pieces that during my training, I was just constantly looking for companies that were doing this kind of work to treat disorders from a biological or psychobiological perspective. And I just wasn't finding anyone. And also at that same time, the DSM Five, the Diagnostic and Statistical Manual for substance use disorders, the criteria that sort of outline what it takes to get a diagnosis had just included the symptom of craving. It might be surprising to people, but it's only been since about 2013 or so, that craving has been an official symptom of a substance use disorder. And I mean, that's despite again, decades, many years of people reporting cravings being an issue that they deal with day in and day out. And so I was aware of this addition of a new symptom, but also I'm aware of the fact that the way that substance use disorders are diagnosed, they're assessed, they're monitored, is entirely subjective, meaning that people are reporting these symptoms in an interview in a one on one kind of subjective interview that people can report what they believe, report what they experience, which is valid information. But sometimes what you're aware of, what the clinician is aware of, might not be what's going on an objective biophysical level. And so I was aware of a certain biomarker that you can measure with brain waves using electroencephalogram or EEG and this biomarker is what leading science says is the biomarker underpinning of craving. And so I felt, well, you know, if there was a way that clinicians had this in their hands as either a diagnostic assistant or as a way to treat people with craving, this could be a valuable medical device that people can use. And so, I can talk more about the specific biomarker, but these were two realizations that I saw that there's a lacking and a need for innovation in this field. [00:10:03] Lindsey Dinneen: Great. Yeah. Okay. So yeah, could you share a little bit more about the biomarker and then how you have found, how you have discovered to affect this and what this device is and how it works? [00:10:14] Scott Burwell: Yeah, so Neurotype Inc., we were founded in 2019. We were founded after we were participating in this workshop at Yale University called Innovation to Impact. It's funded by the National Institute on Drug Abuse. And we really pitched this idea to them as kind of a off the cuff, last day of the workshop pitch event and won first prize in that thing. And that's really what gave us the steam to go ahead and apply for these federal grants to support further development of this biomarker. What the biomarker is, basically we put a headset on you and that headset is kind of like a fitness tracker except other than being like a fitness tracker that's tracking your steps from, you know, a watch or, you know, being a glucose monitor that's on your arm, that senses how much blood sugar you have, this fitness tracker is on your head. It measures the electro physiology that's generated by your brain. And it's entirely passive in that regard. We're not putting any like, you know, electrical stimulations in, but it's just measuring how your brain is acting at all moments. And what we do is that's different from other companies is we're actually recording how your brain responds on a millisecond scale in response to pictures. So we hand somebody an iPad while they're wearing one of these headsets, and we show them a flip book of pictures. Some of those pictures are like chocolate cake, puppy dogs, you know, cute, emotional pictures. Some of those things are boring things like kitchen supplies, office supplies, whatever they might be. And then some of those things are like opioid pill bottle, right? And so, for opioid use disorder, if you are liable for craving, and if you're likely to start reusing after being discharged from treatment, your response to that opioid pill bottle, the brain response, the objective brain response, is going to be very similar to how it responds to, for instance, chocolate cake, than a person that's not at risk for returning to opioid use or other kinds of craving. And so this biomarker is really a biomarker of what's called 'motivated attention.' How interesting you find that stimulus on the screen and how much it grabs your attention. And what we know from psychology is that if something grabs your attention, you're likely to behave in a way that is going to correspond with that. So if it grabs your attention, you're going to act a certain way around that stimulus. And so for people with opioid use disorder, it might be that it stimulates some thought process or some behavioral process in your body that leads you to seek that substance, affiliate yourself with people that have that substance, you know, all sorts of indirect ways that eventually lead you to start using that substance again. And so, we have done a few different research projects funded by the National Institute on Drug Abuse, and these are different projects over time that have really established the core assessment capabilities of the device. And now we're working towards clinical trial validation through a small business innovation research project from National Institute on Drug Abuse that will be a pivotal clinical trial for us. [00:13:30] Lindsey Dinneen: That's really exciting. When does that happen? [00:13:32] Scott Burwell: So, that is part of what's called a fast track project, and we are finishing up our phase one portion of that. And the phase two portion will probably start sometime this coming summer. Yeah. [00:13:45] Lindsey Dinneen: Great. Okay. That's great. And so what is your dream or ultimate ideal goal for the company and for this device? What are you hoping to affect or where are you hoping this device will be used? [00:13:58] Scott Burwell: Yeah. So, our main goal or our first sort of beachhead market, if you will, is the intensive outpatient treatment clinics for substance use disorders or other mental health. It's a certain kind of clinic where people are seen on a pretty regular basis during early recovery when they're still in a kind of high risk period. And in this group of patients, they tend to be in a scenario where they are living at home or living in the wild, so to speak, it's no longer a residential treatment setting. But they are living and being challenged day to day with the triggers in their environment that, that can lead to risk for problems. And the interesting thing about this space though, and this market is that in that space, there really are not many regulated, or any regulated devices, that are being used to manage specifically certain symptoms. And especially none that are applying to brain physiology like ours. And so, it's a pretty big step to bring our device to these spaces because they might be familiar with a blood pressure cuff or people might get blood work done from time to measure other health related risks. But for us, we are bringing an EEG system, and it's a portable EEG with a software device, into a clinic where they've never been before. And so my grand vision for this is really to be, you know, we're not a fix all. We're not a cure-all solution, but we are solution to help one specific slice of somebody's condition, and be a fix for craving in these settings. But if we can get the device in these clinics settings, it opens the door for a whole lot of other biomarker solutions to take place. And so right now, we're just focused on craving, monitoring the craving, but also treating the craving through what's called closed loop biofeedback. But the but the long term vision for this is to do-- we can additionally build out with the same brain kind of assessment, we can build out other kinds of biomarkers. So, those that are related to genetic risk. So we don't have to do like a full genetic test, but we could use that same brain data to to study what are called endo phenotypes, but basically a genetic marker of risk for a certain disease type or a certain disease progression. We could also measure other aspects of distress or you know, other depressive symptomatology or things like this with our measures. So, I think if I were to, at minimum, if we were to be able to make a dent or just get our device into these intensive outpatient clinics, that would be a huge success for me and the company. But, I think much grander speaking, it would open the doors for a lot of more transformative addiction treatment care. [00:16:56] Lindsey Dinneen: Yeah. Yes. Okay. Well, that's incredible and thank you for sharing your vision, 'cause I always love hearing, all right, what's the longterm heart for this company in this project. So that's great. Yeah. Are there any moments that stand out to you, maybe as you're developing this device or maybe even before as you're studying the biomarker and you're thinking through, you know, how can I make a difference in this particular indication? So are there any moments that stand out to you as really affirming to you, "Yes, I am in the right place at the right time. Doing what I'm supposed to be doing." [00:17:32] Scott Burwell: Yeah, I think one piece was when we won first place at that at the Yale workshop that we did. I would say another was just getting each of these grants. We've applied for grants over and over again. And you don't get every one of those grants. But when you get certain projects, and when you're awarded these monies, it is incredibly validating because, you know it's gone through scientific review at the NIH. You know that also at the specific institute, so National Institute on Drug Abuse or Alcoholism or Mental Health-- they're different -- that this is an intense area that they see value. And so when you get these projects, and we've gotten over a million dollars now in these projects, that there's some validation behind it from federal and also a scientific level. So that's one area, but then I would also say that, when talking to clinicians, we talked to clinicians and we talked to some patients about the device, and we demo the device and demo the technology with some clinicians and patients. And, people will come back and be like, "Wow, why is this not out there already? Why don't we have this kind of data?" And to me that is incredibly rewarding to just see people and their immediate responses to the technology, because I don't think anyone really knows that this science or this technology is readily available. It just needs to be packaged in the correct way. And it also has to go through the correct regulatory and reimbursement pass. I mean, to just say "just," I think that's probably an understatement for sure. But, the science has decades of work behind it. And really it's up to us now to move that, to make it to that next milestone, that next goalpost. And that work isn't really science. It's just hard work. [00:19:14] Lindsey Dinneen: Yeah. Yeah, indeed. Well, speaking of hard work, you know, forming a company on its own, working in the medtech field on its own, all of those things are difficult challenges to choose. And I'm curious, how has your personal path been in terms of growing into this leadership role where you are directing this company and directing people. How's that journey been for you too? [00:19:43] Scott Burwell: You know, I think it's been a journey. And when people say that you can't do it on your own, that is 100 percent true. And even if you hear it and you believe it, sometimes I think it takes a lot for me to come to the realization to put that into practice. I tried to do a lot on my own. In the team, I am the CTO, the CEO, the COO, all these different roles that I've assigned myself. We participated and were awarded into the-- NIH has this program called Innovation Core, iCore. And we did this program and one of our mentors there was really harping on the idea of leaning into your what are called core competencies. So what are you actually really good at as a team and as a company? And what are you less good at? And and I think that the more that I've learned to lean into my core competencies, which are really around the science, the translation of the neuroscience, the translation into a clinical tool that can be used, thinking about the vision of our technology. And tried to offload some of the other things, whether it be regulatory or whether it be some aspects of business strategy or other otherwise to, to other people that can help in a fractional sense or whatever to help us out. That's helped me both maintain my role as a leader and keep on doing the work that I think that I can actually contribute to and be useful contributing to, as well as keeping the company afloat in terms of funding and just hitting our milestones on all the different projects that we've been awarded and need to produce for. So, so I would say that, you know, I'm no, I'm not a perfect leader. I'm not a perfect CEO by any means. But I, but as I go on, I kind of learned that you can't do it all yourself, and you can't accomplish everything to the same degree as another person possibly could. And so trying to build good teams, trying to lean on team members that can do certain things, finding the strengths in certain team members and asking them to do the right kind of work given their skill set. But I think that's been a crash course for me. [00:22:00] Lindsey Dinneen: Yes, indeed. Well, that makes complete sense because, you know, like you said at the very beginning, it is a journey, and it is a constant learning and growing process. So yeah, that's, that's fantastic. Well, pivoting the conversation just for fun, imagine that you were to be offered a million dollars to teach a masterclass on anything you want. It can be within your field. It doesn't have to be. What would you choose to teach and why? [00:22:29] Scott Burwell: Oh my gosh. Well, You know, I think that-- I'm not sure anyone would offer me a million dollars for this. But if I had the time, I think If I had the time, I would actually really love to teach a masterclass on how to do this sort of neuroscience innovations. There's a lot. This is a really hot area for startups and innovations, the idea of using neuroscience tools as products. There are companies out there like the Muse headband or there's Nurable, which makes these smart sort of headphones that also measure brainwaves. Neurocity is another company that's doing things for productivity. And I know people at these companies. They're all great companies. And these are some very successful examples. But there's other companies out there too that, that are doing things that I feel are led by engineering first. So, just because you can do something, it doesn't mean that you should do something. And it doesn't mean that there's any validity to what it is that you're doing. So, you know, there's a lot of interest in that. Around developing brain computer interfaces or other kinds of neurological or brain diagnostic or treatment devices. They're doing brain stimulation or brain sensing or biofeedback or all these sorts of buzzwords. I think we're kind of part of that group, honestly, but the difference between us and the others is that we are science led and a lot of these other companies are engineering or technology led. And when you lead through something, when you start by innovating by technology and innovating by engineering, that's great from a perspective of showing others that you have a tool. But without a use for that tool, and without evidence from science that tool actually does something useful, then it's kind of useless. And so a lot of those companies go broke because they don't have a user for that tool or the tool that they built doesn't actually do what they intended it to do. So one thing that I think I would do in this course, if I were to do this course, is to really emphasize like, here's how you can approach certain kinds of biomarkers. Here's the types of biomarkers that people actually think is correlate with a disease, major depression, ADHD, substance use disorders, whatever it is, and actually have a scientific grounding versus building a headset that does XYZ first and not really having a scientific basis. One, one tip I would just offer people is just get a PhD that has the background in that content space first on your team, because they will tell you what the field thinks of it. And a lot of times, the field thinks that a lot of the products that are being developed out there are just snake oil. And so, so really, you know, do your diligence on the science before diving into something. [00:25:27] Lindsey Dinneen: Cool. Yes. I'm sure that would be a fantastic masterclass and very needed. So, all right. Sounds good. All right. And how do you wish to be remembered after you leave this world? [00:25:40] Scott Burwell: Great question. You know, I would love, like I mentioned earlier, for Neurotype to play its part in establishing these kinds of brain biomarkers in the treatment for behavioral and mental health disorders. I would love for us to be a building block for what the future looks like. I think we're using the most current science available to build our innovation. And if we can be sort of that first step into the future, I think that would be so great. And the science will change in the future, but I think that if we can be that stepping stone, that would be ideal. I think on a more personal level, I think I would love for anyone I know, anyone that I come into contact though with, I really want to be remembered as a person that's just been kind to you. If you can remember one moment that that you felt like, "Oh, Scott made me feel good in that scenario" or "Scott was helpful in that scenario." I think that would be a more realistic grab or a closer term grab. So, so, you know, both those things I think would be great. But in the day to day, I really work to at least hope that people remember me and felt that I was kind to them. [00:26:48] Lindsey Dinneen: Yeah, absolutely. Kindness makes all the difference. Yeah! Okay, and then, final question. What is one thing that makes you smile every time you see or think about it? [00:27:00] Scott Burwell: Oh, geez. I think, you know, Is it is it okay to say cute animal memes from Twitter or something? But so... [00:27:08] Lindsey Dinneen: Sure! [00:27:09] Scott Burwell: I love cute animals. I love any cute animal or cute baby thing on Instagram or wherever. But I will also just say, back to the impact aspect of our company, we do research with people. We do early demo testing with people with substance use disorders. And some people struggle, they're in and out of treatment programs five, six times before something really starts to click. And they put in so much hard work and so much effort to keep on their pathway, unique pathway to recovery. And so, you know, I think that I'm really encouraged and really puts gas in my tank when I see people that are doing well and that they're happy. And because there's some degree of pride that person carries around and some, and and maybe that pride was not necessarily there beforehand. And so, you know, I think that I will, regardless if they are achieving their goals and living a happier life because of what Neurotype is doing, or something else, really doesn't matter to me. When I see people that are doing better, it is warming to my heart to see somebody that has made some sort of sustained change in their life that is impacting them in a positive way, because it really does show that people can change. People can do what they want to do and live the life that they want to live in many cases when they. are given the opportunity. And so that's heartwarming to me. [00:28:38] Lindsey Dinneen: Absolutely, yeah, absolutely. Ah, that's wonderful. Well, yes, and also, awesome little cute memes are the best, especially with animals, oh my gosh. [00:28:48] Scott Burwell: I know. Yeah. [00:28:49] Lindsey Dinneen: I spend way too much time looking at baby animals, but I always smile, so, you know, win. [00:28:54] Scott Burwell: Yes, it is. It's the main, it's the main way I get my little like boosts of dopamine throughout the day for sure. [00:29:00] Lindsey Dinneen: Yes, absolutely. Well, Scott, this has been a fantastic conversation. I so appreciate you joining me and sharing more about the work that your company is doing and all the innovation. I'm so excited to watch it continue to succeed. So thank you for spending some time with me today. I appreciate it. [00:29:18] Scott Burwell: Absolutely. Thank you, Lindsey. Thank you. [00:29:20] Lindsey Dinneen: Of course, and we're so honored to be making a donation on your behalf as a thank you for your time today to the Equal Justice Initiative, which provides legal representation to prisoners who may have been wrongfully convicted of crimes, poor prisoners without effective representation, and others who may have been denied a fair trial. So thank you so much for choosing that charity to support. We just wish you continued success as you work to change lives for a better world. And thank you also to our listeners for tuning in. And if you're feeling as inspired as I am at the moment, I would love if you would share this episode with a colleague or two, and we will catch you next time. [00:30:02] Ben Trombold: The Leading Difference is brought to you by Velentium. Velentium is a full-service CDMO with 100% in-house capability to design, develop, and manufacture medical devices from class two wearables to class three active implantable medical devices. Velentium specializes in active implantables, leads, programmers, and accessories across a wide range of indications, such as neuromodulation, deep brain stimulation, cardiac management, and diabetes management. Velentium's core competencies include electrical, firmware, and mechanical design, mobile apps, embedded cybersecurity, human factors and usability, automated test systems, systems engineering, and contract manufacturing. Velentium works with clients worldwide, from startups seeking funding to established Fortune 100 companies. Visit velentium.com to explore your next step in medical device development. ​

In this episode of Winners Find A Way, I sit down with Mark Burwell, a former track and field standout turned entrepreneur, to break down the mindset and strategies that drive high achievers. Mark shares how the discipline, adaptability, and resilience he developed as an athlete became the foundation for his success in business and leadership. Key Takeaways:

Reema 11:17 The post Derch Jnod en Gloowen woa wie nenjepropt appeared first on Lighthouse Gospel Church.

Hebrews 11:8 The post Taking Inventory #4: Fear of Change? appeared first on Lighthouse Gospel Church.

Scripture: Joh 10:10 “Een Stäla kjemt bloos, om to stälen, to schlachten un enne Grunt to brinjen. Ekj sie jekomen, daut Läwen to brinjen, un daut see daut vollopp haben […] The post De Kaumph en daut Familje Läwen appeared first on Lighthouse Gospel Church.

Scripture: Romans 8:1 “There is now therefore no condemnation for those who are in Christ Jesus.” The post Taking Inventory – Fear Of Condemnation? appeared first on Lighthouse Gospel Church.

Reema 10:10-11 10 Wäa von Hoaten jleeft, woat jerajcht, un wäa met däm Mul bekjant, woat seelich.  11 De Schreft sajcht: “Wäaemma aun am jleeft, woat nich toschaund woaren.” The post Jerat derch dän gloowen appeared first on Lighthouse Gospel Church.

Revelation 2:4“But I have this against you, that you have abandoned the love you had at first.” The post Apathy – A Lesson from Ephesus appeared first on Lighthouse Gospel Church.

1 Petrus 2:2-3Soo aus niejebuarne Kjinja no reine Malkj schrieen, sell jie een velangen nojeistliche Noarunk haben, daut jie doaderch waussen un toonämen, wan jiejeschmakjt haben, daut de Har goot […] The post Oppwaussen En Christus appeared first on Lighthouse Gospel Church.

Galatians 1:10“For am I now seeking the approval of man, or of God? Or am I trying to pleaseman? If I were still trying to please man, I would not […] The post Taking Inventory – #2 Fear of Rejection? appeared first on Lighthouse Gospel Church.

Reema 9:23-24 The post Gott haft die jewält appeared first on Lighthouse Gospel Church.

Genesis 3:9 -10 The post Taking Inventory: “Fear of Failure?” appeared first on Lighthouse Gospel Church.

Revelation 19:11 The post Faithful & True appeared first on Lighthouse Gospel Church.

Scripture: Isaiah 9: 6 For to us a child is born, to us a son is given; and the government shall be upon[d] his shoulder, and his name shall be […] The post And His Name Shall Be Called…..Prince Of Peace! appeared first on Lighthouse Gospel Church.

Herod: De Maun Daut Wol Weinachten Doot Moaken The post Herod: De Maun Daut Wol Weinachten Doot Moaken appeared first on Lighthouse Gospel Church.

Case round up:United States v. Burwell, No. 16-3009 (D.C. Cir. Dec. 9, 2024) – crime of violence; divisibility; Federal bank robbery in violation of U.S.C. § 2113(a); common law robbery; Mathis peek; jury instructionsTreez, Inc. v. DHS, Case No. 22-cv-07027 (N.D. Cal. Dec. 3, 2024) – marijuana dispensary; H-1B; aiding and abetting controlled substance act violation Bouarfa v. Mayorkas, et al., No. 23-583 (U.S. Dec. 10, 2024)revocation of I-130 petition; INA § 204(c); jurisdiction; discretion; may; INA § 242(a)(2)(B)(ii) Matter of Dominguez Reyes, 28 I&N Dec. 878 (BIA 2024)amount of loss; circumstance specific approach; INA § 101(a)(43)(D); certification of criminal documents  Quito-Guachichulca v. Garland, No. 23-1069 (8th Cir. Dec. 9, 2024)aggravated felony rape; INA § 101(a)(43)(A); sexual abuse; digital penetration; statutory interpretation; survey of state case law; res judicataMondzali Bopaka v. Garland, No. 21-1384 (1st Cir. Dec. 13, 2024)adverse credibility; motion to reopen to submit new evidence; I-589 errors and omissions; inconsistencies; ineffective assistance of counsel motion to reopen; Republic of the Congo Lopez-Quinteros v. Garland, No. 23-1890 (1st Cir. Dec. 13, 2024)family based particular social group; business owners; mixed motive; gang extortion; El SalvadorSponsors and friends of the podcast!Kurzban Kurzban Tetzeli and Pratt P.A.Immigration, serious injury, and business lawyers serving clients in Florida, California, and all over the world for over 40 years.Docketwise"Modern immigration software & case management"Cerenade"Leader in providing smart, secure, and intuitive cloud-based solutions"Click me!Stafi"Remote staffing solutions for businesses of all sizes"Promo Code: stafi2024Get Started! Promo Code: FREEImmigration Lawyer's Toolboxhttps://immigrationlawyerstoolbox.com/immigration-reviewWant to become a patron?Click here to check out our Patreon Page!CONTACT INFORMATIONEmail: kgregg@kktplaw.comFacebook: @immigrationreviewInstagram: @immigrationreviewTwitter: @immreviewAbout your hostCase notesRecent criminal-immigration article (p.18)Featured in San Diego VoyagerDISCLAIMER & CREDITSSee Eps. 1-200Support the show

Lukas 2 : 1-35 The post Weinachten jeschicht appeared first on Lighthouse Gospel Church.

Scripture: Isaiah 9:6“For to us a child is born, to us a son is given; and the government shall be uponhis shoulder, and his name shall be called Wonderful Counselor, […] The post And His Name Shall Be Called…Everlasting Father appeared first on Lighthouse Gospel Church.

James and Ken talk about watches and gear... again. . . Show Notes  Wrist Check. James - Omega Railmaster 36mm Ken - Arken Alterum . Mentioned: Arken Restock Day of the Jackal Farer Discovery in gunmetal and Jade Nivada Grenchen F77 in Ceramic Timex Q / Noah collaboration Timex Q Stone Dial Timex x Worn and Wound collaboration Lorier x Worn and Wound collaboration Omega Titanium Seamaster 300 Bronze gold and green Doxa Toppers Edition, Great White Baltic Hermetique Bronze collection Delugs CTS Tropic style strap The James Brand Bolen, Burwell and Palmer Rexford RUT Bo Ismono Youtube Olight Oclip Pro . Homework. James - The First Law trilogy audiobooks - Joe Abercrombie Ken - Preowned watch shops: Kibble Watches Bold Timepieces PastPresent Watches Subdial

Think about what your thinking about The post Think about what your thinking about appeared first on Lighthouse Gospel Church.

Johanes 10:10Een Stäla kjemt bloos, om to stälen, to schlachten un enne Grunt to brinjen.Ekj sie jekomen, daut Läwen to brinjen, un daut see daut vollopp haben sellen. The post Gott jeft trig waut de beesa fient jestoolen haft appeared first on Lighthouse Gospel Church.

In this week's episode, Lizzie and Arden dive deep into the landmark Supreme Court case Burwell v. Hobby Lobby Stores, Inc., a pivotal decision that reshaped the conversation about corporate rights, religious freedom, and healthcare! Join them as they unpack the legal arguments, the broader implications for religious liberty and employee rights, and the cultural ripple effects still felt today! Follow us on Twitter and Instagram at @letsgetcivical, @lizzie_the_rock_stewart, and @ardenjulianna. Or visit us at letsgetcivical.com for all the exciting updates! Learn more about your ad choices. Visit megaphone.fm/adchoices

Isaiah 9:6 The post And His Name Shall Be Called……Mighty God appeared first on Lighthouse Gospel Church.

2 Timotäus 4:3 The post “Doa woat eene Tiet Komen” appeared first on Lighthouse Gospel Church.

Reema 7:5 Soolang aus wie onbekjieet em Fleesch wieren, wieren de sintelje Liedenschoften, derch daut Jesaz jereizt, un onse Jläda aun de Oabeit Frucht to droagen, dee toom Doot fieed. The post Wan wie daut woaren no komen waut wie jelieet senn appeared first on Lighthouse Gospel Church.

Isaiah 9:6 For to us a child is born, to us a son is given; and the government shall be upon[d] his shoulder, and his name shall be called[e] Wonderful […] The post His Name Shall Be Called, Wonderful Counselor! appeared first on Lighthouse Gospel Church.

Cennetta was on the podcast in October 2020 for SewOver50 Thursday. Today this episode is number 6 in the Top 20 Countdown and her podcast has been downloaded over 15,000 times. Now the great news is Cennetta is teaching sewing at Calumet Middle School in Chicago. The school has established an after-school enrichment program that includes tailoring and sewing, culinary, theatre, music and more. Cennetta says ‘It's the best!' One of the great things about bringing people for you to listen to on Sew Organised Style podcast is that not only do you hear their stories, I stay in contact with them because we share so many life experiences. Cennetta has continually shared her sewing knowledge with me and the sewing community through her generous fitting posts. It's a thrill to know she's now sharing her knowledge with middle school students.

Filippa 1:6Ekj hab doarenn goode Hopninj, daut dee, dee daut goode Woakj en juntaunjefongen haft, dee woat daut uk foadich moaken bat aun Jesus Christussienen Dach The post Hee Schoft Noch On Mie appeared first on Lighthouse Gospel Church.

1 Timothy 1:5“The aim of our charge is love that issues from a pure heart and a goodconscience and a sincere faith.” The post The Bottom Line Is appeared first on Lighthouse Gospel Church.

Scripture: Luke 1:1-4“1 Inasmuch as many have undertaken to compile a narrative of the things thathave been accomplished among us, 2 just as those who from the beginningwere eyewitnesses and […] The post Does History Matter? appeared first on Lighthouse Gospel Church.

Reema 6:7Wiels wäa jestorwen es, es frie von Sind. The post Kaun eene de jestorwen es noch Sindjen? appeared first on Lighthouse Gospel Church.

United States v. Bryan Burwell

“Gott es onse Tooflucht uk onse Krauft. Hee es eene jewenschte Help en grooteNoot.” Psalm 46:2 The post Gott Halpt un woakt äwa Ons! appeared first on Lighthouse Gospel Church.

Matthew 11:20-24 The post Learning From Jesus #17- “Compelled To Confront” appeared first on Lighthouse Gospel Church.

Reema 5:8 Oba Gott wees ons siene Leew doaren, daut Christus fa ons storf, aus wie noch Sinda wieren. The post Fräd met Gott, es daut mäajlich appeared first on Lighthouse Gospel Church.

1 Peter 1:3-4 “Blessed be the God and Father of our Lord Jesus Christ! According to his great mercy, he has caused us to be born again to a living […] The post An Inheritance Imperishable appeared first on Lighthouse Gospel Church.

Elizabeth Burwell is able to come across as both Warm and Strong at the same time, something many leaders strive to emulate but few are able to master. Listeners will get an insider look at how she is able to strike this balance, walking in confidence while truly understanding that how you make people FEEL is key to followership. Elizabeth discusses the value of direct communication, especially when it is difficult. She shares the importance of being curious, recognizing that there is always more to learn, and how important it is to see others in the same way. Elizabeth is an extraordinary leader who boldly shares what is usually unspoken in business settings, what is at the core of her leadership doctrine…the power of love.   Executive Access is produced by The Ideal Life, a platform that provides coaching, community, and content for people to grow both personally and professionally.

Reema 3:21“Oba nu es Gott met siene Jerajchtichkjeit verendach jekomen, onen daut Jesaz,wan uk daut Jesaz selfst un de Profeeten aul doavon räden deeden.” The post Jesus es ãwa Aules appeared first on Lighthouse Gospel Church.

John 17:21“That they may all be one, just as you, Father, are in me, and I in you, that they alsomay be in us, so that the world may believe […] The post Learning From Jesus #16- “Fellowship is Dependent” appeared first on Lighthouse Gospel Church.

Lamentations 3:21-23 The post Great is Your Faithfulness appeared first on Lighthouse Gospel Church.

Psalm 149:4“For the Lord takes pleasure in his people; he adorns the humble withsalvation.” The post Our Purpose on Earth appeared first on Lighthouse Gospel Church.

On the latest edition of the GigEm247 Podcast, Andrew Hattersley and Carter Karels are joined by the Toledo Blade's Michael Burwell to preview the matchup between Texas A&M and Bowling Green. SUBSCRIBE TO THIS CHANNEL: #247Sports #TexasA&M #GigEm #Aggies Follow our hosts on Twitter: @Perroni247, @AndrewHatts AUDIO ‘The Gig'Em247 Podcast' is available on Apple Podcasts, Spotify, Stitcher, Google Podcasts and wherever else you listen to podcasts. -LEAVE a 5-star review on Apple Podcasts: https://247sports.com/podcast/gig-em-247-a-texas-am-sports-podcast-62 -STREAM on Spotify: https://open.spotify.com/show/3E5fSHMva2idP6ehJR26X2?si=fb4b7953c1684113 WEBSITE -READ our content from Gig'Em247: https://gigem247.com/ SOCIAL MEDIA -FOLLOW Gig'Em247 on Twitter: https://twitter.com › gigem247 To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Send us a textIn this episode Matt talks with an active duty United States Coast Guard search and rescue pilot, Commander Bill Burwell. He has served over 18 years with assignments as duty pilot, instructor pilot and chief of aviation operations. Listen in as Bill dives into the challenges of rotary-wing flying, hair-raising rescue missions, and extreme duty stations Please enjoy the show!Video of perilous rescue recounted by Bill in the episode:https://www.dvidshub.net/video/640450/coast-guard-rescues-4-fishermen-60-miles-off-maine-coastLearn more about Coast Guard aviation careers: https://www.gocoastguard.com/careers/officer/aviationThe OpTempo Training Group website for an updated list of classes:https://optempotraining.com/@optempotraining on Instagram and FacebookFind us on Youtube at https://www.youtube.com/channel/UC4kBpYUjDdve9BULTHRF2Bw/featured?view_as=subscriberLowa BootsIG: @lowa.professional and @lowabootshttps://www.lowaboots.com/

Today on the podcast we're with Josh and Sara Holmquist of Normal Roasting Company in Burwell, Nebraska (pop. 1,079). In this episode you'll find out how Josh and Sarah bought a coffee company on a whim and grew it from a hobby to what is now multiple businesses. They talk about how they dealt with overwhelming growth, building an iconic brand, scaling your business in the early years, plus the wholesale side of their business and the amazing community they have built there. These two are such a fun couple and they truly have built an incredible brand!Check out more on the blog.SHOW NOTESBurwell, NebraskaArcadia, NebraskaTheory Coffee TechNormal Wholesale CollectiveFOLLOW NORMAL ROASTING COMPANYFACEBOOKINSTAGRAMWEBSITEBRANDED BY RURAL REVIVALDid you start out the year with big brand goals but still haven't found the time to work on those? If that's you, we've still got four months left in the year and we can help make this happen for you through Branded by Rural Revival — our rural design studio that specifically focuses on helping small businesses and small towns. From websites to logos, marketing assets, course building, and podcast setup, we are ready to help you build a brand you love. Find out more and check out our latest work at brandedbyruralrevival.co.MORE FROM RURAL REVIVALWEBSITEINSTAGRAMFACEBOOK

      Adam Stolzer is the Burwell Jr./Sr. High School Principal located in Burwell, Ne. Adam is an educational leader who makes a ruckus with his mobile office, Longhorn Support Days, and helps facilitate bringing out students' passions. Adam takes great pride in leaving a daily legacy of being a model of support for students.    Show Highlights   Strategies aimed at enhancing student engagement and behavior. Improvement in absences with motivational reward days off. Power of Purple and Passion in Education.  Mobile office strategy to increase accessibility and communication. Exposing students to diverse opportunities and hands-on learning. Belief that tough conversations lead to growth and evolution.   “Unless we can have honest conversations with ourselves, with our staff, with our peers, colleagues, I don't think that evolution is there. And eventually, if you don't have tough conversations, you get stuck in a status quo because everybody's just comfortable. And if you want to grow, you want to learn something new, you have to get uncomfortable.” -Adam Stolzer    Get the episode transcript here!   Adam's Resources & Contact Info:   Website: Professional Website Cornhusker Chats X/Twitter Facebook: Burwell Jr-Sr High School X/Twitter: BHSLonghorns Read my latest book! Learn why the ABCs of powerful professional development™ work – Grow your skills by integrating more Authenticity, Belonging, and Challenge into your life and leadership.   Read Mastermind: Unlocking Talent Within Every School Leader today! Apply to the Mastermind The mastermind is changing the landscape of professional development for school leaders. 100% of our members agree that the mastermind is the #1 way they grow their leadership skills. Apply to the mastermind today!   How We Serve Leaders   The School Leadership Scorecard™ Identify your highest leverage areas for growth this year in 10 -minutes or less.    https://betterleadersbetterschools.com/scorecard   Month-to-Month Principal Checklist As a principal with so much to do, you might be thinking, where do I even start?   When you download The Principal Checklist you'll get 12-months of general tasks that every campus need to do Space to write your campus specific items. Space to reflect and not what worked as well as a space of what didn't work Go to https://betterleadersbetterschools.com/principal-checklist to download now.   Ruckus Maker Mindset Tool™ The “secret” to peak performance is ot complicated.  It's a plan on how to optimize the five fundamentals found in The Ruckus Maker Mindset Tool™. https://betterleadersbetterschools.com/mindset   The Positive Spotlight Tool™ Energy flows to where attention goes! If you want to get more of what you want, when you want it as a school leader I have a tool for you…   Download The Positive Spotlight Tool™ for free here: https://betterleadersbetterschools.com/positive   The Ruckus Maker 8-Step Goal Setting Tool™ Are you ready to accomplish more? With less effort and in less time? When you download The Ruckus Maker 8-Step Goal Setting Tool™  I'll send you the tool and a short 8-minute coaching video that shows you how to work smarter, not harder…and create more value for your school campus.   Download The Ruckus Maker 8-Step Goal Setting Tool™  for free at https://betterleadersbetterschools.com/goals SHOW SPONSORS:     Quest Food Management Services   Quest Food Management Services provides high-quality, scratch-made food in K-12 schools and universities across the country, prioritizing the health and wellness of students and elevating the cafeteria dining experience.  Quest offers a full-service approach to their school partners, bringing 40 years of expertise through every stage of program development and nurturing a true sense of community through interactive events such as student food committees. For more information about Quest Food Management Services, www.questfms.com     IXL IXL is the most widely used online learning and teaching platform for K to 12. Over 1 million teachers use IXL in their classrooms every day for one reason: They love it. Visit IXL.com to lead your school towards data-driven excellence today.   Copyright © 2024 Twelve Practices LLC